This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_KIDNEY_CLEAR_CELL_CARCINOMA_EXALLC for full statistics.
Clear cell adenocarcinoma of kidney
C3_KIDNEY_CLEAR_CELL_CARCINOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1549 |
4. Check minimum number of eventsNone |
1549 |
5. Include endpointsNone |
1549 |
6. Filter based on genotype QC (FinnGen only) |
1549 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Clear cell adenocarcinoma of kidney
based on the number of shared cases.
Similar with more cases:
- Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of kidney, except renal pelvis
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1549 | 589 | 960 |
| Unadjusted period prevalence (%) | 0.34 | 0.20 | 0.42 |
| Median age at first event (years) | 67.78 | 68.40 | 67.40 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1406
- Matched controls
- 14059
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
317.7
323.0
1067
137
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
1406
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
538.5
323.0
413
11
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3545.4
323.0
1347
87
KAC10
NOMESCO Finland
Total nephrectomy with capsule
142.3
315.4
328
30
B01AB10
ATC
tinzaparin; parenteral
13.6
243.2
459
485
JN4AD
NOMESCO Finland
Body CT examination
10.9
233.7
502
682
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
118.1
213.6
228
23
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
153.1
211.3
220
17
KAD00
NOMESCO Finland
Partial nephrectomy
116.1
194.3
208
21
197
Kela drug reimbursment
Sunitinib
178.3
180.5
186
12
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.5
178.3
343
354
TPH07
NOMESCO Finland
Cathetrisation of artery
7.3
169.8
474
919
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.9
166.8
344
404
JN4CD
NOMESCO Finland
Very extensive body CT
13.5
166.3
306
284
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.4
158.7
491
1081
JN4BD
NOMESCO Finland
Extensive body CT
6.5
151.6
462
988
L01XE04
ATC
[U] sunitinib; oral
154.0
132.9
139
10
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
29.0
128.3
176
69
1502
Kela drug reimbursment
Cabozantinib
339.2
123.4
123
*
130
Kela drug reimbursment
Malignant tumour
6.4
123.1
367
737
3012
Kela drug reimbursment
Cabozantinib
323.6
118.1
118
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
35.5
113.0
147
46
B01AB05
ATC
enoxaparin; parenteral
3.7
111.1
718
3096
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
19.5
108.3
168
97
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
107.3
657
2688
159
Kela drug reimbursment
Pazopanib
210.4
95.7
98
5
WX402
NOMESCO Finland
General anaesthesia
4.0
88.2
423
1357
L01XE26
ATC
[U] cabozantinib; oral
800.9
78.1
76
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
8.5
77.3
178
235
U75
ICPC
Malignant neoplasm of kidney
267.5
75.2
76
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
74.8
870
5120
L01EX07
ATC
cabozantinib; oral
370.3
71.3
71
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.8
67.9
165
236
322
Kela drug reimbursment
Sunitinib
183.9
67.7
70
*
N02BE01
ATC
paracetamol; systemic, rectal
4.6
63.8
1315
10659
L01XE11
ATC
[U] pazopanib; oral
140.5
63.4
67
5
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.3
58.1
147
222
N02AX02
ATC
tramadol; systemic, rectal
2.5
56.7
767
4597
WZC30
NOMESCO Finland
Teaching
3.3
56.5
334
1208
KAC00
NOMESCO Finland
Nephrectomy
49.8
51.5
62
13
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
50.7
592
3222
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
45.5
209
611
158
Kela drug reimbursment
Everolimus
92.9
41.0
45
5
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
40.9
409
2001
168
Kela drug reimbursment
Axitinib
408.7
40.3
40
*
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
408.7
40.3
40
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
15.7
40.0
66
44
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.0
37.7
127
273
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
36.6
367
1781
R4110
NOMESCO Finland
Physiotherapy
2.2
36.5
482
2675
C64.80
ICD-10 Finland
Wilms tumour
130.1
35.9
38
*
N02AA05
ATC
oxycodone; systemic
2.6
35.8
299
1310
XX3DW
NOMESCO Finland
Time consuming IT work
2.9
35.5
239
919
KA3LT
NOMESCO Finland
Njurlesion coagulation
68.5
35.1
40
6
WX704
NOMESCO Finland
Intubation
3.6
34.2
165
497
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.6
33.6
101
190
R31
ICD-10 Finland
Unspecified haematuria
2.8
33.5
237
936
S18
ICPC
Laceration/cut
2.0
31.9
702
4738
343
Kela drug reimbursment
Pazopanib
116.0
31.8
34
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
31.5
153
463
C08CA01
ATC
amlodipine; oral
2.0
30.9
632
4132
WX110
NOMESCO Finland
Local anesthesy
2.0
30.2
969
7454
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
29.9
344
1763
Z51.5
ICD-10 Finland
Palliative care
3.4
29.8
154
489
L01EX01
ATC
sunitinib; oral
158.3
29.8
31
*
L01XE10
ATC
[U] everolimus; oral
81.9
28.8
32
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.9
28.7
83
149
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
28.7
185
686
U14
ICPC
Kidney symptom/complaint
8.7
28.4
62
74
L01XE17
ATC
[U] axitinib; oral
286.9
27.8
28
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
26.0
27.6
38
15
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
27.0
951
7391
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
26.2
298
1504
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
6.4
26.2
70
114
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
31.6
26.0
34
11
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
9.0
25.9
55
63
UKC02
NOMESCO Finland
Cystoscopy
2.1
25.6
327
1737
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.1
24.2
138
470
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
10.3
22.9
45
45
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
22.9
203
904
WX725
NOMESCO Finland
Noninvasive ventilation
3.6
22.3
104
304
N18.8
ICD-10 Finland
Other chronic renal failure
4.3
21.5
81
196
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.2
21.2
116
383
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
12.8
19.9
35
28
361
Kela drug reimbursment
Axitinib
202.7
19.6
20
*
ZXA05
NOMESCO Finland
Left side
1.8
19.5
408
2579
PHN71
NOMESCO Finland
Excision of tumor mass from inferior vena cava
+∞
18.8
18
*
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
18.8
18
*
340
Kela drug reimbursment
Everolimus
101.4
18.6
20
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
12.0
18.3
33
28
BCA30
NOMESCO Finland
Unilateral adrenalectomy
25.4
18.2
25
10
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
18.1
123
469
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
9.2
17.9
37
41
SPAT1153
SPAT
Removal of sutures
1.7
17.8
503
3472
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.8
17.8
119
447
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
67.5
17.7
20
*
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
17.7
102
349
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
9.4
17.2
35
38
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.5
17.2
51
96
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
40.6
16.3
20
5
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
6.3
15.5
41
67
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
15.4
182
922
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
9.3
15.2
31
34
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.0
14.9
87
302
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.5
14.7
52
119
L01EX03
ATC
pazopanib; oral
+∞
14.6
14
*
TK800
NOMESCO Finland
Hemodialysis
3.9
14.1
57
149
C03CA01
ATC
furosemide; systemic
1.6
14.0
431
2996
ZXA00
NOMESCO Finland
Right side
1.6
13.7
407
2800
L01EK01
ATC
axitinib; oral
+∞
13.6
13
*
PC5DT
NOMESCO Finland
Embolisation of tumor of kidney
+∞
13.6
13
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
7.3
13.3
31
43
ZXC96
NOMESCO Finland
Robot assisted procedure
3.2
13.2
68
217
WX290
NOMESCO Finland
Other blockade of nerve
1.6
12.6
497
3658
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.4
12.5
29
40
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
131.1
12.5
13
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.5
12.3
98
410
A02BC02
ATC
pantoprazole; systemic
1.5
12.3
885
7438
N28.1
ICD-10 Finland
Cyst of kidney
4.9
12.2
39
81
M05BX04
ATC
denosumab; parenteral
2.7
12.2
85
331
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
16.0
12.1
19
12
ZX120
NOMESCO Finland
Intravenous
2.1
12.0
145
739
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
11.6
255
1600
A11CC03
ATC
alfacalcidol; systemic
3.8
11.6
49
134
V03AE01
ATC
polystyrene sulfonate; oral
5.1
11.4
35
70
H02AB02
ATC
dexamethasone; systemic
2.0
11.2
149
788
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
20.2
11.1
16
8
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.7
11.1
47
129
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.4
11.1
93
401
KH1AD
NOMESCO Finland
CT of urinary organs
2.9
11.0
68
246
198
Kela drug reimbursment
Sorafenib
12.0
10.8
19
16
L01XE05
ATC
[U] sorafenib; oral
21.6
10.7
15
7
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.9
10.7
164
917
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.7
10.6
70
264
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
14.3
10.5
17
12
A10BH05
ATC
linagliptin; oral
2.4
10.2
90
397
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.8
10.2
64
235
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.2
10.1
52
167
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
9.2
10.0
20
22
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
9.8
237
1526
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.2
9.8
50
160
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
9.7
479
3656
205
Kela drug reimbursment
Chronic hypertension
1.5
9.6
431
3221
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
4.3
9.6
34
80
R50.9
ICD-10 Finland
Fever, unspecified
1.8
9.5
187
1132
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
15.1
9.5
15
10
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
100.7
9.4
10
*
Z90.5
ICD-10 Finland
Acquired absence of kidney
30.2
9.4
12
*
D41
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of urinary organs
+∞
9.4
9
*
M04AA01
ATC
allopurinol; systemic
1.7
9.4
205
1284
J01DB01
ATC
cefalexin; oral
1.5
9.3
1090
9807
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
36.9
9.0
11
*
J01MA02
ATC
ciprofloxacin; systemic
1.4
9.0
532
4189
WW500
NOMESCO Finland
Blood transfusion
2.5
8.9
68
280
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
8.9
131
719
AA1AD
NOMESCO Finland
CT of head and brain
1.5
8.9
352
2556
RJ128
NOMESCO Finland
NA
12.6
8.9
15
12
WX892
NOMESCO Finland
Monitored bed care
1.9
8.8
121
652
WF004
NOMESCO Finland
Palliative radiotherapy
3.3
8.6
42
131
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.8
8.6
34
90
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
10.1
8.5
16
16
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
90.6
8.4
9
*
R4190
NOMESCO Finland
Nutritional therapy
2.9
8.3
48
168
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
9.5
8.3
16
17
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.0
8.2
31
79
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.2
8.1
41
132
U06
ICPC
Haematuria
2.9
8.1
47
165
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.0
8.1
44
149
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.4
8.1
66
284
NK6AN
NOMESCO Finland
Total body bone isotope imaging
2.7
8.0
52
196
105
Kela drug reimbursment
Adrenal cortical hypofunction
22.1
8.0
11
5
WX600
NOMESCO Finland
Single shot through catheter
5.7
7.8
21
37
B01AB04
ATC
dalteparin; parenteral
2.2
7.8
79
375
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
3.9
7.8
30
78
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
7.8
145
866
WX002
NOMESCO Finland
Sedation and analgesia
1.5
7.7
269
1891
A04AA02
ATC
granisetron; systemic, transdermal
2.1
7.7
83
406
H02AB09
ATC
hydrocortisone; systemic
3.2
7.6
38
122
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.7
7.5
48
179
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
7.5
141
843
1XC17
NOMESCO Finland
NA
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
4.0
7.2
27
69
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
7.1
160
1006
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
7.0
227
1567
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.0
398
3079
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
7.6
6.9
15
20
N18.0
ICD-10 Finland
End-stage renal disease
4.1
6.9
25
62
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.4
6.8
23
53
N03AX16
ATC
pregabalin; oral
1.5
6.8
292
2142
Z49.0
ICD-10 Finland
Preparatory care for dialysis
4.3
6.7
23
54
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
6.7
151
951
N99.0
ICD-10 Finland
Postprocedural renal failure
22.6
6.7
9
*
A06AH03
ATC
naloxegol; oral
4.5
6.7
22
50
E0000UV
ATC
NA
1.4
6.6
463
3709
SPAT1254
SPAT
Administration of medicine
1.6
6.6
188
1257
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.1
6.6
24
60
G04CA02
ATC
tamsulosin; oral
1.4
6.6
380
2946
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
6.5
85
448
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
6.5
97
540
E87.5
ICD-10 Finland
Hyperkalaemia
3.2
6.4
31
98
L01EG02
ATC
everolimus; oral (mammalian target of rapamycin kinase inhibitors (mtor))
70.1
6.4
7
*
PHN70
NOMESCO Finland
Plastic repair of inferior vena cava
70.1
6.4
7
*
M907, C6488
ICD-10 Finland
NA
70.1
6.4
7
*
C02AC05
ATC
moxonidine; oral
2.0
6.4
72
361
J01MA12
ATC
levofloxacin; systemic
1.5
6.4
253
1828
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
8.2
6.3
13
16
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
18.1
6.3
9
5
K46.9
ICD-10 Finland
Unspecified abdominal hernia without obstruction or gangrene
7.1
6.2
14
20
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
8.6
6.1
12
14
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.1
6.0
31
103
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037121) Protein [Mass/volume] in Urine
325
503
7.91
208.76
3.0
3.3
g/l
0.3
0.2
0.20
214
203
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1163
6419
4.26
141.33
5.1
4.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
351
858
5.00
136.90
7.1
10.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1100
6154
3.72
123.61
8.3
5.0
g/l
34.5
35.0
2.26
1047
5722
(3002173) Hemoglobin [Mass/volume] in Arterial blood
450
1525
3.75
111.11
7.0
8.7
g/l
120.5
121.8
0.66
439
1469
(3016502) Oxygen saturation in Arterial blood
472
1658
3.66
110.30
6.8
8.2
%
96.8
95.5
6.81
457
1601
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1112
6523
3.50
110.09
9.3
6.4
mmol/l
1.2
1.2
0.55
1054
5886
(3031040) Bacteria [#/volume] in Urine by Automated count
1331
8775
4.67
109.79
5.9
4.6
e6/l
914.1
1909.0
0.42
14
146
(3044640) Blood type and Crossmatch panel - Blood
866
4400
3.20
109.47
2.9
2.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
486
1773
3.54
106.67
4.5
4.2
u/l
224.4
250.2
3.32
476
1680
(3003396) Base excess in Arterial blood by calculation
494
1830
3.50
105.72
6.7
7.8
mmol/l
-0.1
1.1
9.91
398
1418
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
492
1832
3.47
104.24
6.8
7.8
kpa
5.3
5.1
6.22
476
1746
(3027801) Oxygen [Partial pressure] in Arterial blood
491
1833
3.46
103.51
6.7
7.8
kpa
13.9
11.9
11.48
475
1749
(3002582) Erythrocytes [#/volume] in Urine
839
4315
3.06
101.46
4.8
3.4
e6/l
78.3
88.9
0.16
718
3375
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1139
7077
3.30
96.12
10.9
7.3
mmol/l
1.2
1.2
1.06
949
5972
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1163
7322
3.36
95.78
12.9
6.4
umol/l
10.8
12.0
2.89
1127
6971
(3020779) Urea [Moles/volume] in Serum or Plasma
405
1405
3.55
94.93
7.8
7.4
mmol/l
11.0
10.3
1.12
386
1335
(3013826) Glucose [Moles/volume] in Serum or Plasma
1253
8288
3.68
94.24
7.2
5.2
mmol/l
6.9
6.9
0.31
1217
7826
(3030467) Casts [#/volume] in Urine by Automated count
775
3948
2.93
93.09
4.5
3.2
e6/l
0.4
0.5
0.14
653
3023
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1440
10561
6.17
91.34
15.8
7.9
u/l
81.9
79.5
1.36
1418
9933
(36304419) Bacteria [Presence] in Urine
750
3796
2.89
90.52
4.4
3.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
283
824
3.98
85.35
7.8
10.1
mmol/l
23.5
24.3
4.48
274
766
(3018095) Leukocytes [#/volume] in Urine
873
4905
2.79
84.35
5.4
3.9
e6/l
67.8
123.6
1.28
733
3605
(3032080) INR in Blood by Coagulation assay
1012
6140
2.87
84.04
10.9
10.6
inr
1.2
1.3
3.81
301
1680
(3026782) Osmolality of Urine
600
2805
2.86
82.46
3.8
2.8
mosm/kgh2o
549.2
558.0
0.49
531
2392
(3035637) Corticotropin [Mass/volume] in Plasma
114
151
8.07
81.90
1.6
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
362
1276
3.40
81.59
8.9
8.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
478
1986
3.03
81.49
8.4
7.0
mmol/l
104.7
104.3
1.81
469
1928
(3000850) Epithelial cells [#/volume] in Urine
621
3001
2.78
79.51
3.4
2.6
e6/l
4.0
4.6
0.95
561
2662
(40768804) Tissue Pathology biopsy report
897
5222
2.71
78.93
2.5
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
769
4193
2.66
76.64
5.0
4.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1287
9138
3.41
75.88
6.4
4.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
767
4368
2.50
67.12
4.7
2.6
u/l
67.5
57.7
1.35
728
4030
(3018418) pH of Serum or Plasma
742
4182
2.49
66.15
6.5
4.3
ph
7.4
7.4
2.70
178
802
(4035726)
333
1257
3.10
65.72
1.4
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1127
7730
2.68
65.12
15.1
9.2
e9/l
4.3
4.2
0.21
997
6761
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
646
3439
2.51
64.91
2.7
2.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
289
1015
3.27
64.35
8.4
9.5
%
95.4
94.0
9.51
289
1008
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
288
1013
3.26
63.95
8.2
9.4
%
0.5
0.7
16.51
288
1005
(3003458) Phosphate [Moles/volume] in Serum or Plasma
445
1996
2.73
63.58
7.9
6.1
mmol/l
1.1
1.0
1.57
423
1845
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
289
1022
3.25
63.57
8.1
9.3
%
0.9
1.4
10.99
289
1015
(3014111) Lactate [Moles/volume] in Serum or Plasma
341
1344
2.97
62.04
7.4
7.3
mmol/l
1.2
1.4
5.24
333
1295
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
488
2319
2.61
61.81
4.2
3.1
e6/l
2.0
1.6
0.56
319
1304
(3012095) Magnesium [Moles/volume] in Serum or Plasma
498
2406
2.58
60.78
4.5
3.4
mmol/l
0.8
0.8
0.27
476
2255
(3015377) Calcium [Moles/volume] in Serum or Plasma
786
4676
2.38
60.43
7.5
3.4
mmol/l
2.4
2.4
1.45
725
4021
(3026008) Bacteria identified in Urine by Culture
712
4082
2.38
59.27
3.4
3.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
624
3507
2.31
52.91
5.4
4.1
%
91.7
86.1
6.38
616
3433
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
490
2488
2.42
52.46
4.0
2.9
e6/l
0.8
1.1
1.20
319
1464
(3036481) Cortisol [Moles/volume] in Serum or Plasma
286
1147
2.83
49.51
5.9
2.1
nmol/l
384.8
370.0
0.61
277
1050
(3018677) aPTT in Platelet poor plasma by Coagulation assay
452
2328
2.33
45.88
2.2
2.0
s
29.9
30.0
0.15
447
2256
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
689
4235
2.13
44.79
5.1
3.2
u/l
31.0
38.9
1.29
660
4023
(42870588) Differential panel, method unspecified - Blood
736
4658
2.11
44.08
7.0
5.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
902
6248
2.06
41.28
7.7
6.4
%
8.7
9.0
1.49
856
5834
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
484
2660
2.19
41.28
6.9
3.1
mmol/l
2.5
2.5
2.94
455
2340
(3002030) Lymphocytes/100 leukocytes in Blood
912
6353
2.06
40.97
7.4
6.3
%
25.6
26.7
2.09
860
5903
(3006504) Eosinophils/100 leukocytes in Blood
896
6225
2.04
40.26
7.4
6.1
%
2.9
2.9
0.03
849
5793
(3022096) Basophils/100 leukocytes in Blood
878
6068
2.03
39.89
7.3
6.1
%
0.6
0.7
2.47
832
5654
(3018010) Neutrophils/100 leukocytes in Blood
898
6259
2.03
39.80
7.2
6.0
%
59.6
57.9
3.47
849
5844
(3049717) Cytology report of Urine Cyto stain
188
674
3.04
39.46
2.3
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
569
3378
2.08
39.31
1.4
1.3
—
—
—
0
0
(3039000) Anion gap in Blood
128
366
3.72
38.58
5.5
8.2
mmol/l
11.3
11.2
0.14
118
328
(3018572) Chloride [Moles/volume] in Blood
128
366
3.72
38.58
5.5
8.2
mmol/l
105.8
105.6
0.34
118
328
(3022948) Iron [Moles/volume] in Serum or Plasma
421
2279
2.16
36.64
3.2
2.6
umol/l
11.0
12.8
4.88
397
2118
(3001604) Monocytes [#/volume] in Blood
924
6626
1.98
36.35
7.0
5.7
e9/l
0.6
0.6
1.45
800
5679
(3019198) Lymphocytes [#/volume] in Blood
938
6765
1.98
36.24
7.1
5.9
e9/l
1.9
1.9
0.04
824
5913
(3006315) Basophils [#/volume] in Blood
926
6656
1.97
36.05
7.1
5.8
e9/l
0.0
0.0
1.40
803
5714
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
382
2020
2.18
35.09
3.3
2.6
%
20.5
22.8
2.30
323
1716
(3013115) Eosinophils [#/volume] in Blood
943
6858
1.96
35.02
7.2
6.0
e9/l
0.2
0.2
0.07
828
5987
(3004789) Transferrin [Mass/volume] in Serum or Plasma
395
2126
2.15
34.63
3.2
2.6
g/l
2.1
2.3
7.31
375
1975
(3047181) Lactate [Moles/volume] in Blood
148
500
3.17
34.27
5.3
7.2
mmol/l
1.2
1.3
1.53
136
437
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
160
574
2.99
33.38
3.0
2.6
u/ml
0.4
0.3
0.68
72
334
(1616796) Gas panel - Central venous blood
113
333
3.58
32.50
3.8
4.0
—
—
—
0
0
(3002256) Pathology report gross observation
334
1746
2.16
31.18
1.4
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1467
12945
3.52
30.06
27.5
16.2
mg/l
35.4
26.2
17.31
1399
10464
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
68
147
4.79
29.62
1.3
1.3
nmol/l
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
873
6395
1.84
29.43
4.8
3.8
estimate
0.0
0.0
0.00
218
1193
(3019060) Gas panel - Arterial blood
233
1082
2.36
28.78
4.7
5.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1205
9820
2.02
28.77
4.8
4.2
mm/h
18.7
13.1
14.79
1121
9029
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
166
662
2.69
28.30
5.3
6.0
%
1.8
1.6
1.49
155
621
(3007930) Methemoglobin/Hemoglobin.total in Blood
164
654
2.69
27.96
5.3
6.0
%
1.0
0.9
3.44
153
614
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
294
1520
2.15
27.95
4.1
3.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
873
6476
1.80
27.41
4.8
3.8
estimate
0.0
0.0
0.37
218
1148
(3009214) Lutropin [Units/volume] in Serum or Plasma
84
237
3.69
25.74
1.5
1.3
u/l
15.3
7.8
3.18
68
189
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
291
1543
2.09
25.72
3.1
2.8
umol/l
7.4
8.8
0.62
263
1380
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
69
169
4.23
25.72
1.4
1.3
nmol/l
0.2
0.4
—
7
17
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
227
1106
2.23
24.84
5.6
3.9
ng/l
129.7
95.7
3.39
202
960
(3021601) Nitrite [Presence] in Urine by Test strip
853
6399
1.74
24.67
6.7
5.1
estimate
0.0
0.0
0.00
227
1209
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
404
2434
1.89
24.64
1.9
1.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
215
1031
2.26
24.43
6.3
7.4
mmol/l
24.2
24.5
0.67
203
961
(40761536) Microorganisms panel - Urine sediment
226
1110
2.21
24.22
5.1
3.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
66
166
4.11
23.76
1.5
1.4
iu/l
30.8
31.2
0.03
47
136
(3012501) Base excess in Blood by calculation
99
329
3.15
23.47
4.3
5.2
mmol/l
2.4
2.6
0.25
68
223
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
63
157
4.14
22.96
1.4
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
506
3342
1.76
22.48
5.1
3.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
160
702
2.43
22.23
6.1
4.0
mmol/l
23.8
24.2
0.76
152
618
(3002032) Base excess in Venous blood by calculation
264
1423
2.03
22.06
5.8
3.7
mmol/l
1.5
2.0
1.17
219
1122
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
228
1167
2.12
21.89
6.6
4.1
mmol/l
1.2
1.2
0.96
211
1023
(3021447) Carbon dioxide [Partial pressure] in Venous blood
263
1425
2.02
21.63
5.8
3.7
kpa
6.0
5.8
1.71
257
1378
(3020630) Protein [Mass/volume] in Serum or Plasma
245
1300
2.05
21.33
3.1
2.9
g/l
65.9
66.4
0.39
226
1192
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
24
25
9.74
20.59
11.7
2.0
u/l
52.8
40.9
—
14
8
(3027945) Reticulocytes/100 erythrocytes in Blood
306
1794
1.88
19.81
2.5
2.6
%
1.8
1.8
0.20
280
1591
(3010421) pH of Blood
104
392
2.77
19.68
4.4
4.9
ph
7.4
7.4
0.42
98
324
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
227
1205
2.04
19.65
1.7
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
492
3343
1.69
19.11
10.9
6.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1489
13722
3.20
19.04
35.9
19.2
mmol/l
139.0
139.7
20.01
1484
13380
(3023103) Potassium [Moles/volume] in Serum or Plasma
1490
13759
3.18
18.53
36.2
19.3
mmol/l
4.1
4.0
26.51
1484
13396
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
732
5574
1.59
17.61
4.6
3.9
ng/l
40.8
57.8
0.97
595
4214
(3009508) Creatinine [Moles/volume] in Urine
635
4677
1.61
17.56
3.4
3.2
mmol/l
7.3
7.6
1.15
518
3887
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
75
252
3.08
17.47
1.4
1.8
iu/l
2.1
5.0
3.46
18
89
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
270
1590
1.85
17.02
3.2
4.2
ug/l
9.8
20.2
0.67
218
1327
(3012516) Albumin [Mass/volume] in Urine
621
4579
1.59
16.92
3.4
3.3
mg/l
732.2
268.2
1.26
400
2972
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
199
1061
2.00
16.91
1.8
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
215
1178
1.96
16.89
1.7
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
504
3555
1.62
16.40
2.3
2.2
mg/l
3.2
3.1
0.49
434
3027
(40761511) CBC panel - Blood by Automated count
1455
13379
2.44
16.39
29.1
15.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1120
9537
1.63
15.97
7.4
3.7
pmol/l
15.1
15.0
0.85
1022
8510
(3020682) Albumin/Creatinine [Ratio] in Urine
644
4836
1.57
15.95
4.2
4.1
mg/mmol
24.2
8.5
5.02
409
3129
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
125
570
2.30
15.84
3.0
3.5
u/ml
1356.1
2582.1
0.24
110
490
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
224
1272
1.89
15.76
3.3
2.4
u/l
37.2
40.4
0.28
201
1091
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1489
13874
2.89
15.69
38.9
19.3
umol/l
109.2
82.6
46.76
1489
13868
(3002385) Erythrocyte distribution width [Ratio]
1205
10481
1.67
15.47
37.8
19.9
%
14.3
13.8
18.77
1198
10239
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
649
4908
1.55
15.43
5.4
4.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
240
1410
1.83
15.13
1.9
2.2
g/l
0.2
0.2
0.29
228
1320
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
91
370
2.55
14.84
2.6
2.9
mg/l
1.9
1.7
1.75
82
332
(3011985) Renin [Units/volume] in Plasma
54
167
3.31
14.45
1.9
1.3
mu/l
22.9
70.1
2.07
46
145
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1309
11705
1.76
14.44
8.0
4.6
mu/l
2.2
2.1
0.34
1212
10522
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
276
1712
1.74
14.44
1.8
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
673
5183
1.53
14.43
3.4
2.8
ug/l
215.3
164.0
2.90
606
4703
(3042936) Bacteria identified in Isolate by Culture
325
2110
1.68
14.39
2.1
2.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
743
5851
1.52
14.30
17.7
10.2
e9/l
0.0
0.0
0.90
609
4788
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
147
748
2.07
14.14
1.6
1.8
g/l
1.8
1.6
1.58
124
651
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
275
1716
1.73
14.06
1.8
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
130
634
2.15
13.97
4.9
3.3
pmol/l
4.3
4.4
0.54
120
557
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
177
968
1.94
13.89
4.7
3.6
mmol/l
1.4
1.9
0.92
124
728
(3023520) Reticulocytes [#/volume] in Blood
229
1368
1.79
13.59
2.9
2.7
e9/l
69.8
70.2
0.05
170
1062
(3026493) Urate [Moles/volume] in Serum or Plasma
520
3834
1.54
13.38
3.2
2.9
umol/l
2327.1
6220.6
1.71
450
3302
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
406
2834
1.59
13.31
5.0
4.0
ng/l
2447.2
431.6
0.47
351
2371
(3044889) 12 lead EKG panel
1121
9709
1.56
13.29
4.8
4.2
—
—
—
0
0
(3009343) pH of Capillary blood
181
1013
1.89
13.23
4.7
3.6
ph
7.4
7.4
0.16
38
124
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
84
350
2.48
13.03
1.3
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
181
1025
1.87
12.75
4.7
3.6
kpa
5.1
5.1
0.12
168
948
(40767503) Oxygen content in Capillary blood by calculation
80
334
2.47
12.37
3.1
2.6
%
16.6
16.1
0.39
49
172
(46235355) HIV 1 and 2 tests - Meaningful Use set
228
1397
1.74
12.34
1.7
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
58
211
2.82
11.79
1.4
1.5
e6/l
1294.3
1626.2
0.51
39
152
(3028626) Oxygen [Partial pressure] in Capillary blood
83
361
2.37
11.74
3.0
3.0
kpa
8.0
7.9
0.07
78
327
(3021901) Oxygen saturation in Capillary blood
73
309
2.43
10.98
3.1
2.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1259
11372
1.57
10.70
32.0
17.5
%
38.1
39.6
5.10
799
7460
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1469
13860
2.16
10.53
18.6
11.3
u/l
27.5
26.9
0.27
1441
13341
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
77
342
2.32
10.41
1.3
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
48
169
2.90
10.39
1.4
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
391
2842
1.50
10.28
1.7
1.7
mg/l
1.8
1.4
1.27
329
2226
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
125
676
1.92
10.11
1.9
1.9
ug/l
1.0
1.9
1.00
113
601
(3029937) Albumin [Presence] in Urine by Test strip
470
3556
1.46
10.07
5.2
4.1
estimate
0.0
0.0
0.16
204
1138
(3012441) Differential panel - Pleural fluid
49
178
2.81
10.03
1.3
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
87
414
2.17
9.98
3.9
3.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
245
1615
1.61
9.93
1.8
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
160
942
1.78
9.89
1.9
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
959
8266
1.42
9.84
3.7
3.2
u/l
67.7
56.7
2.11
884
7600
(3024354) Oxygen [Partial pressure] in Venous blood
190
1177
1.70
9.81
4.1
2.9
kpa
4.6
4.5
0.18
182
1139
(3028308) Erythrocytes [#/volume] in Pleural fluid
50
187
2.73
9.70
1.3
1.4
e6/l
34208.6
102334.5
0.97
25
109
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
44
156
2.87
9.43
1.2
1.4
u/l
338.6
345.6
0.03
44
151
(3007461) Platelets [#/volume] in Blood
1493
14238
2.34
9.38
44.4
23.8
e9/l
245.0
240.9
1.48
1481
13850
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
559
4413
1.42
9.37
2.1
2.2
u/l
256.5
232.0
0.21
525
4128
(3026361) Erythrocytes [#/volume] in Blood
1493
14242
2.34
9.30
44.2
23.8
e12/l
4.4
4.5
12.07
1476
13804
(3010813) Leukocytes [#/volume] in Blood
1493
14244
2.33
9.26
44.3
23.9
e9/l
7.2
6.8
8.78
1477
13807
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
86
422
2.10
9.14
1.9
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1342
12413
1.61
9.11
32.5
15.2
ml/min/173m2
62.2
76.5
94.45
1240
10304
(3015235) Bicarbonate [Moles/volume] in Capillary blood
86
423
2.09
9.08
3.5
3.2
mmol/l
23.8
25.0
1.92
79
365
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
66
295
2.29
8.83
3.2
5.8
iu/ml
1362.3
768.4
—
8
46
(40768446) Kidney Pathology biopsy report
22
52
4.28
8.67
1.4
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
574
4606
1.39
8.55
3.1
3.1
ng/l
1914.6
1455.0
1.26
515
3976
(3030905) Polymorphonuclear cells [#/volume] in Blood
58
249
2.38
8.51
3.8
3.2
e9/l
4.5
4.4
0.19
58
249
(21494814) CD8 cells/100 lymphocytes in Specimen
21
49
4.33
8.41
1.9
2.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
81
3.50
8.39
1.9
2.3
%
15.2
15.2
—
6
29
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
19
41
4.68
8.36
2.1
2.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
27
77
3.55
8.26
2.0
2.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
46
180
2.60
8.21
1.4
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
59
262
2.30
8.04
3.9
3.5
%
59.6
58.9
0.16
59
262
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
41
155
2.69
7.84
1.3
1.4
pmol/l
230.0
295.4
0.87
33
120
(3013512) EKG study
542
4360
1.37
7.78
4.9
4.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
448
3499
1.39
7.67
1.6
1.6
nmol/l
18.7
20.4
1.59
389
2936
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
708
5966
1.34
7.42
2.1
2.0
pmol/l
92.3
94.0
0.42
408
3150
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
34
121
2.85
7.29
1.2
1.3
u/l
10.3
12.8
0.57
29
112
(3004588) Protein electrophoresis panel - Serum or Plasma
171
1112
1.60
7.27
1.9
2.7
—
—
—
0
0
(3016750) Collection duration of Urine
29
97
3.03
6.94
1.7
2.1
min
495.9
497.8
0.04
22
66
(3006184) Hemoglobin [Mass/volume] in Capillary blood
68
341
2.04
6.89
3.0
2.2
g/l
131.7
129.4
0.29
59
258
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
107
625
1.76
6.82
1.3
1.2
iu/ml
182.0
139.8
0.33
33
228
(3024928) Oxygen saturation in Venous blood
67
336
2.04
6.79
3.1
2.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
52
238
2.23
6.65
3.6
3.6
—
—
—
0
0
(3019225) pH of Specimen
211
1481
1.49
6.36
7.2
4.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
161
1066
1.57
6.35
4.4
4.1
%
0.5
0.6
0.23
52
266
(3021879) Hepatitis B virus core Ab [Presence] in Serum
122
755
1.67
6.33
1.4
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
31
115
2.73
6.20
1.9
2.2
e9/l
1.1
1.0
0.07
24
66
(3017181) Myelocytes/100 leukocytes in Blood
175
1188
1.53
6.17
4.6
4.3
%
0.6
0.9
0.88
68
374
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
23
72
3.23
6.16
2.4
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
48
221
2.21
6.08
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
764
6627
1.30
6.07
2.6
2.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
96
564
1.75
6.02
2.2
2.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
81
453
1.83
5.99
1.3
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
136
878
1.60
5.97
1.6
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
156
1044
1.55
5.87
4.7
4.5
%
0.0
0.4
0.59
59
289
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
93
547
1.74
5.82
2.1
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
164
1119
1.52
5.65
4.7
4.4
%
0.0
0.1
1.52
67
340
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
72
397
1.85
5.59
2.4
2.3
ug/min
178.2
103.1
0.54
41
246
(40760892) CBC W Ordered Manual Differential panel - Blood
349
2740
1.35
5.55
5.6
4.7
—
—
—
0
0
(3036489) Thrombin time
83
480
1.77
5.52
2.2
1.9
s
22.3
21.6
0.33
77
431
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
16
43
3.75
5.37
1.5
1.3
%
27.5
28.5
0.04
16
32
(3034860) Kappa light chains.free [Mass/volume] in Serum
90
538
1.71
5.34
2.2
3.9
mg/l
55.4
65.9
0.34
68
441
(40768797) Stomach Pathology biopsy report
254
1915
1.39
5.17
1.3
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
605
1.66
5.17
1.5
2.8
g/l
4.1
3.8
1.06
63
442
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
606
1.66
5.14
1.5
2.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
606
1.66
5.14
1.6
2.8
g/l
8.2
7.4
2.20
66
458
(3051611) Lipemic interference index of Serum or Plasma
33
140
2.39
5.08
4.6
3.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
29
116
2.53
5.05
1.2
1.4
u/l
11.5
13.9
0.71
29
110
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
89
539
1.69
5.05
2.2
3.9
mg/l
117.5
77.0
0.26
66
444
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
617
5293
1.28
5.04
2.5
2.2
nmol/l
79.2
78.0
0.44
561
4648
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
25
93
2.72
5.02
1.6
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
97
603
1.65
4.99
2.1
2.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
31
129
2.43
4.98
1.9
2.3
ml
717.8
643.0
0.47
22
81
(3022313) Gas panel - Capillary blood
115
747
1.58
4.95
5.1
3.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
352
2817
1.32
4.85
1.8
1.8
nmol/l
1087.0
1172.6
1.04
287
2121
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
572
1.65
4.74
1.5
2.8
g/l
10.9
10.5
0.31
72
491
(3011397) Hemoglobin [Presence] in Urine by Test strip
382
3111
1.30
4.62
4.0
3.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
69
402
1.75
4.52
1.3
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
37
174
2.15
4.52
1.1
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
26
105
2.50
4.47
1.2
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
23
88
2.64
4.40
5.3
3.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
561
1.62
4.37
1.6
2.8
g/l
3.4
3.1
1.58
65
449
(40765089) Chromosome analysis panel - Blood by G-banded
9
12
7.54
4.35
1.0
1.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
61
349
1.78
4.27
1.8
2.7
umol/l
27.8
37.7
2.03
44
295
(3000570) Elastase.pancreatic [Mass/mass] in Stool
70
423
1.69
4.06
1.3
1.5
ug/g
239.2
266.7
0.57
46
253
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
14
42
3.35
4.04
1.2
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
28
3.95
3.98
1.0
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
183
1365
1.39
3.97
2.9
3.0
ng/l
282.4
206.6
0.81
172
1256
(3025941) Bacteria identified in Stool by Culture
99
657
1.54
3.93
1.3
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
28
125
2.26
3.91
1.1
1.7
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
49
271
1.83
3.86
1.5
1.3
mmol/l
52.0
61.0
1.08
38
217
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
32
152
2.13
3.86
2.2
2.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
32
155
2.09
3.68
2.4
2.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
135
1844
0.71
3.66
9.9
7.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
31
149
2.10
3.64
1.0
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
74
2.59
3.55
1.7
1.6
u/l
2.7
8.2
1.33
13
42
(3021162) Amylase [Enzymatic activity/volume] in Specimen
10
26
3.86
3.52
4.6
2.8
u/l
149.9
3246.4
—
10
26
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
59
358
1.67
3.42
1.2
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
65
406
1.63
3.37
2.4
4.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
253
2035
1.29
3.30
22.9
27.6
inr
1.5
1.4
0.60
37
280
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
38
205
1.88
3.27
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
17
66
2.59
3.22
6.0
6.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
33
171
1.95
3.20
1.1
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
28
3.59
3.20
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
267
1.74
3.14
1.3
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
40
224
1.81
3.08
1.7
2.5
—
—
—
0
0
(3000012) Reticulocyte production index
18
74
2.45
3.05
1.6
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
37
203
1.84
3.05
1.1
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
77
514
1.52
3.04
1.8
2.8
g/l
1.1
1.3
0.18
65
449
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
46
271
1.72
3.00
1.1
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
20
88
2.29
2.94
1.3
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
20
88
2.29
2.94
1.3
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
85
591
1.46
2.78
1.9
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
217
1.77
2.78
1.2
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
538
0.55
2.77
1.7
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
68
452
1.53
2.76
1.4
2.7
g/l
0.0
0.0
1.36
62
418
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
41
240
1.73
2.76
1.3
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
78
2.32
2.75
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
256
1.70
2.73
1.8
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
71
479
1.51
2.70
1.5
2.6
g/l
36.6
37.3
0.41
61
415
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
105
2.11
2.69
1.2
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
190
1513
1.29
2.69
1.4
1.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
8
19
4.23
2.68
1.0
1.6
umol/l
2.5
1.9
—
8
19
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
126
2.00
2.66
1.3
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
137
1044
1.34
2.65
2.5
2.9
g/l
10.6
10.8
0.25
125
957
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
13
49
2.67
2.62
1.2
1.3
ug/l
317.7
85.2
—
6
21
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
58
377
1.56
2.62
1.2
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
27
141
1.93
2.61
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
99
719
1.40
2.58
5.6
3.9
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
64
428
1.52
2.55
1.4
2.7
g/l
0.0
0.0
0.00
59
395
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
37
216
1.73
2.53
1.3
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
38
224
1.71
2.52
1.9
1.4
u/ml
113.2
129.7
0.29
13
35
(3005570) Glucose [Moles/volume] in Urine
26
136
1.93
2.51
1.7
2.3
—
—
—
0
0
(3035880) pH of Pleural fluid
21
102
2.07
2.47
1.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
333
2855
1.21
2.45
5.4
4.2
kg/l
1.0
1.0
0.17
66
411
(3043410) Blood group antigens tested for on Red Blood Cells
12
45
2.68
2.45
1.9
2.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
83
2.18
2.41
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
117
886
1.35
2.38
3.3
3.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
52
340
1.55
2.32
2.5
3.5
u/ml
19.7
1141.2
0.88
46
319
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
24
127
1.90
2.26
1.2
1.2
u/l
51.4
53.4
0.09
16
94
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
15
66
2.29
2.24
2.1
3.8
u/l
222.4
211.1
0.22
15
66
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
101
756
1.36
2.23
2.3
2.4
—
—
—
0
0
(3036603) Volume of Urine
19
93
2.06
2.22
1.6
1.5
ml
1691.2
1895.3
—
6
22
(3004451) EKG impression Narrative
19
93
2.06
2.22
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
49
727
0.66
2.15
1.3
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
35
213
1.66
2.11
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
154
1235
1.27
2.10
3.6
3.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
415
3678
1.18
2.09
1.7
1.7
mmol/l
1.6
1.4
4.91
342
3039
(3019977) pH of Arterial blood
18
89
2.03
2.06
1.9
3.1
ph
7.4
7.4
—
7
33
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
118
1.88
2.02
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
27
155
1.76
2.01
1.2
1.4
mosm/kgh2o
276.8
277.6
0.04
19
111
(3017732) Neutrophils [#/volume] in Blood
114
885
1.31
2.00
4.4
3.4
e9/l
4.4
4.1
0.47
88
655
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46
304
1.53
1.99
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46
304
1.53
1.99
1.3
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
30
178
1.70
1.99
4.1
4.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
38
241
1.59
1.97
1.3
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
77
2.09
1.97
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
713
6605
1.15
1.96
5.1
5.1
ug/l
2.6
2.8
0.43
631
5909
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
60
840
0.70
1.96
1.9
1.9
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
27
2.97
1.93
2.1
2.3
mmol/l
1.2
1.2
—
8
27
(1761482) Bacteria [#/volume] in Urine by Culture
55
381
1.46
1.92
7.0
4.9
—
—
—
0
0
(4024509)
23
128
1.81
1.90
1.2
1.5
—
—
—
0
0
(3000492) Spirometry study
145
1176
1.26
1.82
1.4
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
46
311
1.49
1.82
1.7
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
15
73
2.07
1.80
2.0
2.9
ml
1691.3
1893.1
0.32
15
66
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1332
12949
1.20
1.79
5.8
5.0
mmol/l
6.2
6.1
2.78
1195
11659
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
41
2.45
1.75
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
41
2.45
1.75
1.2
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
41
2.45
1.75
2.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
157
1292
1.24
1.75
2.9
2.2
ug/g
359.2
163.1
0.74
124
1031
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
18
3.34
1.74
2.2
1.7
ng/l
252.0
151.9
—
6
18
(40768795) Lymph node Pathology biopsy report
23
132
1.75
1.74
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
139
1130
1.25
1.72
4.5
2.9
ml/min/173m2
48.5
61.9
6.69
83
457
(3016330) Potassium [Moles/time] in 24 hour Urine
5
13
3.85
1.71
1.0
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
218
1.57
1.71
1.2
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
29
179
1.63
1.70
4.2
6.6
mmol/l
7.0
7.5
0.37
22
148
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
55
2.19
1.67
2.0
2.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
97
1.87
1.66
1.2
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
44
302
1.47
1.64
1.3
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
14
3.58
1.61
2.0
2.7
u/field
0.0
0.5
—
5
14
(3045142) Bone marrow Pathology biopsy report
29
182
1.60
1.61
1.2
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
51
363
1.42
1.59
1.2
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
45
313
1.45
1.58
2.2
2.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
11
50
2.21
1.57
8.0
9.1
mmol/l
24.3
25.5
0.40
11
45
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
21
2.86
1.50
4.3
4.8
—
—
—
0
0
(4034850)
29
440
0.65
1.49
14.9
10.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
23
139
1.66
1.48
1.9
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
132
1.68
1.46
1.6
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
73
1.93
1.44
1.4
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
73
1.93
1.44
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
73
1.93
1.44
1.1
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
22
2.73
1.43
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
15
81
1.86
1.40
2.7
2.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
40
2.26
1.40
2.2
1.3
ug/l
14.0
9.4
—
9
40
(3008898) HLA-B27 [Presence]
18
300
0.60
1.39
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
17
97
1.76
1.35
1.2
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
28
183
1.54
1.35
1.3
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
120
1.68
1.34
1.1
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
51
376
1.37
1.33
1.2
1.3
—
10.9
—
0
7
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
45
325
1.40
1.33
1.7
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
26
168
1.56
1.32
1.2
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
187
1615
1.18
1.31
1.2
1.3
titre
336.4
501.1
1.48
39
369
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1282
12496
1.15
1.30
6.9
6.4
mmol/mol
41.4
40.7
1.57
1187
11466
(3023511) Choriogonadotropin [Units/volume] in Urine
6
24
2.51
1.30
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
44
318
1.39
1.30
1.5
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
76
1.85
1.30
2.6
2.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
14
76
1.85
1.30
2.2
1.4
u/field
2.9
5.4
0.44
14
54
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
19
115
1.66
1.25
1.2
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
65
504
1.30
1.24
1.4
1.5
titre
112.0
342.6
—
5
23
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
45
2.01
1.23
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
26
2.31
1.18
1.3
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
212
0.56
1.18
1.2
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
20
2.50
1.15
1.2
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
20
2.50
1.15
1.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
318
1.36
1.14
1.3
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
33
233
1.43
1.13
1.3
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
29
200
1.46
1.12
2.0
2.5
mg/l
16.5
26.7
—
10
49
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
40
293
1.37
1.12
1.1
1.2
—
414.3
—
0
7
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
218
1.43
1.09
1.3
1.2
u/ml
225.1
301.0
1.04
19
125
(3023419) Bacteria identified in Sputum by Culture
31
218
1.43
1.09
1.6
2.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
41
1.96
1.09
2.0
2.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
28
194
1.45
1.07
3.6
2.7
—
—
—
0
0
(3020891) Body temperature
80
651
1.24
1.06
5.9
4.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
272
2458
1.13
1.04
1.2
1.2
u/ml
2.5
1.7
0.21
60
635
(3035320) C reactive protein [Mass/volume] in Body fluid
15
90
1.67
1.04
2.0
2.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
46
1.96
1.03
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
54
421
1.29
1.02
1.6
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
23
155
1.49
1.01
1.2
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
68
1.77
1.00
1.1
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
49
1.84
0.98
2.3
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
49
1.84
0.98
2.3
2.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
337
3100
1.11
0.96
1.7
1.7
pmol/l
46350757.9
31548281.0
0.12
274
2539
(3028026) IgM [Mass/volume] in Serum or Plasma
98
826
1.20
0.95
2.2
1.8
g/l
1.2
1.4
0.45
90
751
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
133
1.51
0.94
1.1
1.1
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
7
37
1.90
0.94
9.6
3.1
ml/dl
15.3
15.1
—
7
32
(1761868) Lipid panel - Serum or Plasma
394
4234
0.91
0.94
3.4
3.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
86
1.63
0.91
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
325
0.70
0.90
4.1
3.6
mg/l
36.5
28.1
0.41
18
203
(3014765) Yersinia sp identified in Stool by Organism specific culture
47
368
1.29
0.89
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
31
228
1.37
0.89
1.6
1.4
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
12
71
1.70
0.89
1.1
1.3
u/l
504.8
440.6
0.06
12
65
(3011648) Oxygen content in Venous blood
19
127
1.50
0.88
1.8
1.8
%
9.3
11.0
1.02
19
127
(4146454)
25
177
1.42
0.88
2.4
2.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
54
431
1.26
0.88
1.2
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
10
56
1.79
0.88
21.2
16.4
nmol/l
1615.2
1432.9
—
10
56
(42529406) Shigella sp [Presence] in Stool by Culture
47
370
1.28
0.86
1.1
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
18
120
1.51
0.85
1.8
2.0
u/field
5.2
2.2
—
10
46
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
31
411
0.75
0.84
1.3
1.8
nmol/l
41.9
41.1
0.06
31
389
(3044290) Cell count panel - Cerebral spinal fluid
35
266
1.32
0.83
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
46
365
1.27
0.80
1.1
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
20
139
1.44
0.79
3.3
3.2
mg/l
89.3
20.3
0.52
12
112
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
15
98
1.54
0.78
1.3
1.2
mmol/l
2.7
2.0
0.72
15
91
(40768443) Skin Pathology biopsy report
72
603
1.20
0.78
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
183
1650
1.12
0.76
1.6
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
20
141
1.42
0.74
1.4
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
27
201
1.35
0.74
2.1
2.4
u/ml
41.0
282.8
0.60
27
194
(3052592) Norovirus Ag [Presence] in Stool
5
24
2.09
0.74
1.2
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
158
1417
1.13
0.73
1.3
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
25
2.00
0.72
1.0
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
22
159
1.39
0.72
1.2
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
76
1.58
0.71
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
76
1.58
0.71
1.2
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
40
1.75
0.71
7.3
5.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
40
1.75
0.71
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
41
1.71
0.70
1.4
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
85
1.53
0.69
1.5
2.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
161
1.37
0.68
3.3
3.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
42
338
1.25
0.68
2.1
1.6
—
—
—
0
0
(4010399)
91
1044
0.86
0.67
1.3
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
60
503
1.20
0.67
5.1
4.0
mmol/l
4.0
4.0
0.15
55
464
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
43
1.63
0.67
1.6
1.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
40
321
1.25
0.66
5.8
3.5
mmol/l
6.9
7.7
1.68
40
315
(3007164) IgA [Mass/volume] in Serum or Plasma
242
2235
1.10
0.66
1.6
1.5
g/l
2.9
2.7
0.33
151
1344
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
162
1.36
0.66
1.1
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
5
28
1.79
0.66
1.4
1.4
—
159.1
—
0
7
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
11
70
1.58
0.65
1.4
1.0
u/l
1.0
1.3
—
6
39
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
95
1.48
0.64
1.4
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
14
95
1.48
0.64
1.6
2.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
39
314
1.25
0.64
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
25
190
1.32
0.63
1.3
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
32
252
1.28
0.63
1.7
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
27
346
0.78
0.61
2.0
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
3.4
2.9
mg/l
8.9
7.0
—
5
25
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
1.8
1.4
ug/l
0.4
0.4
—
5
18
(4133840)
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
18
130
1.39
0.61
1.9
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
113
1.42
0.61
2.2
2.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(4094501)
32
400
0.80
0.60
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.7
—
16.7
—
0
21
(3017446) Testosterone [Moles/volume] in Serum or Plasma
137
1236
1.12
0.60
2.0
2.2
nmol/l
11.8
13.2
1.31
120
1077
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
80
1.50
0.60
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
80
1.50
0.60
1.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
12
80
1.50
0.60
1.1
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
98
866
1.14
0.59
1.1
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
52
1.54
0.59
1.4
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
173
0.69
0.57
1.2
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
26
202
1.29
0.57
1.0
1.1
iu/ml
1.7
75.9
—
9
37
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
54
1.48
0.57
1.1
2.6
—
47849.3
—
0
10
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
132
1.37
0.57
1.1
2.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
88
0.57
0.56
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
88
0.57
0.56
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
88
0.57
0.56
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
44
367
1.20
0.54
1.4
2.1
mg/l
11.6
12.2
0.19
39
337
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
24
186
1.29
0.54
2.0
1.6
%
81.4
63.1
2.51
16
121
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
74
1.49
0.53
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
169
1.31
0.53
1.2
1.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
62
1.45
0.53
1.1
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
39
1.54
0.53
1.2
1.1
miu/ml
680.5
1577.7
—
6
39
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
63
1.43
0.52
1.0
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
63
1.43
0.52
1.0
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
28
348
0.80
0.52
1.5
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
35
287
1.22
0.51
1.6
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
24
188
1.28
0.51
1.2
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
118
1068
1.11
0.51
1.3
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
65
1.39
0.50
1.0
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
22
171
1.29
0.50
1.2
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
171
1.29
0.50
1.2
1.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
24
190
1.27
0.48
1.3
1.5
—
—
—
0
0
(4015189)
7
47
1.49
0.47
2.0
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
67
589
1.14
0.47
1.3
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
8
117
0.68
0.46
1.1
1.3
—
33.6
—
0
7
(3048879) Bone marrow aspiration report
7
50
1.40
0.45
1.4
1.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
95
1.37
0.43
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
181
1936
0.93
0.42
1.2
1.2
u/ml
17.7
12.8
0.23
45
707
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
93
0.64
0.42
1.3
3.4
%
13.1
13.2
—
6
93
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
32
1.56
0.42
1.4
1.3
%
124.6
107.5
—
5
26
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
286
1.19
0.41
1.2
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
58
1.38
0.41
1.1
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
151
1402
1.09
0.41
2.2
2.5
ug/l
6.3
7.6
0.32
135
1251
(3036048) Francisella tularensis Ab [Titer] in Serum
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
33
1.52
0.41
1.0
1.3
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
46
398
1.16
0.41
1.7
1.6
iu/ml
0.7
16.5
—
5
73
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
18.1
—
0
16
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
15
114
1.32
0.40
1.5
3.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
138
0.72
0.40
1.5
1.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
34
1.47
0.40
2.4
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
22
177
1.25
0.40
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
21
168
1.25
0.40
1.2
1.7
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
40
343
1.17
0.40
5.8
3.3
mmol/l
1.4
1.6
0.79
40
336
(3028707) Methadone [Presence] in Urine by Screen method
12
88
1.37
0.40
1.2
2.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
61
1.31
0.39
1.1
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
40.9
—
0
19
(3009015) Lactate [Moles/volume] in Synovial fluid
0
19
0.00
0.39
0.0
1.3
—
6.9
—
0
11
(4062490)
15
115
1.31
0.39
1.1
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
3.2
3.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
25
206
1.22
0.38
1.4
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
65
581
1.12
0.38
1.4
1.9
u/l
37.8
38.6
0.12
54
501
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
36
418
0.86
0.37
2.1
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
35
300
1.17
0.36
2.1
1.6
nmol/l
0.9
0.8
0.41
30
245
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
145
1.24
0.33
1.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
88
0.68
0.33
1.3
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
74
1.35
0.32
1.3
1.1
nmol/l
124.3
145.9
—
10
74
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
193
1831
1.06
0.32
4.4
4.8
%
30.3
32.5
2.12
136
1194
(3042111) Morphology [Interpretation] in Bone marrow Narrative
33
286
1.16
0.31
1.5
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
75
1.34
0.30
17.7
14.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
75
1.34
0.30
1.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
75
1.34
0.30
1.2
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
111
1.26
0.30
1.1
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
84
1.31
0.30
1.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
84
1.31
0.30
1.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
84
1.31
0.30
1.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
84
1.31
0.30
1.0
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
30
259
1.16
0.30
1.8
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
212
2025
1.05
0.28
1.2
1.3
iu/ml
39.7
37.6
0.06
64
645
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
12
94
1.28
0.28
2.4
2.8
%
30.4
37.6
—
5
31
(3032773) Endomysium IgG Ab [Titer] in Serum
11
85
1.30
0.28
1.0
1.1
—
—
—
0
0
(4027681)
8
64
1.25
0.27
1.3
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
14
113
1.24
0.26
1.0
1.3
g/l
3.0
2.9
—
9
80
(3024139) IgG subclass 3 [Mass/volume] in Serum
14
113
1.24
0.26
1.0
1.3
g/l
0.4
0.4
—
9
78
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
113
1.24
0.26
1.0
1.3
g/l
6.9
7.0
—
9
78
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
95
1.27
0.26
1.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
160
1.19
0.25
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
22
188
1.17
0.25
1.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
188
1.17
0.25
1.3
1.5
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
15
123
1.22
0.25
1.1
1.1
—
40.0
—
0
5
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1339
13302
1.05
0.25
5.2
5.4
mmol/l
2.6
2.6
2.99
1194
12102
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
142
1.20
0.24
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
142
1.20
0.24
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
142
1.20
0.24
1.2
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
96
1.25
0.24
1.4
2.1
e6/l
517.6
710.3
—
5
42
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
11
87
1.27
0.24
1.5
1.1
mg/l
60.3
46.6
0.40
11
77
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
133
1.21
0.24
1.4
1.3
%
13.0
28.3
—
7
85
(3005988) Vibrio sp identified in Specimen by Organism specific culture
22
189
1.17
0.24
1.3
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1299
12900
1.04
0.23
4.7
4.7
mmol/l
1.3
1.4
23.44
1162
11718
(3020650) Glucose [Presence] in Urine
5
38
1.32
0.23
1.4
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
38
1.32
0.23
1.6
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
13
106
1.23
0.23
1.1
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
88
1.25
0.22
1.3
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
37
333
1.11
0.22
1.1
1.2
u/ml
3.7
4.3
—
7
44
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
172
1.16
0.22
1.2
1.2
u/ml
3.1
4.8
—
7
60
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
42
1.19
0.21
1.4
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
42
1.19
0.21
1.4
2.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
10
0.00
0.21
0.0
2.2
—
1.3
—
0
10
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
24
211
1.14
0.20
1.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
12
144
0.83
0.20
2.0
1.4
e6/l
78834.3
85438.5
—
7
100
(44790048)
20
174
1.15
0.19
1.3
1.6
—
—
—
0
0
(44790047)
20
174
1.15
0.19
1.3
1.6
—
—
—
0
0
(44806118)
20
174
1.15
0.19
1.3
1.6
—
—
—
0
0
(44790049)
20
174
1.15
0.19
1.3
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
146
1.17
0.19
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1308
13006
1.04
0.19
4.8
4.8
mmol/l
4.4
4.5
4.02
1185
11909
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
541
5316
1.03
0.19
4.3
4.5
%
22.9
21.5
1.48
285
2682
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
53
1.13
0.18
1.2
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
53
1.13
0.18
1.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
185
1.14
0.18
1.6
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
66
0.76
0.17
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
31
283
1.10
0.16
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1257
12502
1.03
0.15
4.2
4.3
mmol/l
1.5
1.3
13.65
1121
11263
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
168
1.13
0.15
1.2
1.2
u/ml
4.6
5.7
—
9
81
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
49
458
1.07
0.15
1.3
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
78
1.15
0.15
2.6
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
80
1.13
0.15
1.3
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
110
0.82
0.13
1.4
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
161
1.12
0.13
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
142
1.13
0.12
1.4
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
10
85
1.18
0.12
1.3
1.1
mg/l
378.3
306.1
—
10
77
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
32
297
1.08
0.12
1.5
1.4
e6/l
919.1
720.8
0.09
24
238
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
32
297
1.08
0.12
1.5
1.3
e6/l
98.7
41.5
0.26
24
231
(3004716) Salmonella sp identified in Stool by Organism specific culture
53
502
1.06
0.12
1.1
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
17
189
0.90
0.12
1.6
1.7
g/l
1.6
0.9
0.48
11
145
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
136
1399
0.97
0.11
1.6
1.8
%
1.5
1.6
1.27
115
1185
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
86
1.16
0.11
3.5
4.0
—
—
—
0
0
(1002224) Polysomnography panel
41
434
0.94
0.10
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
388
3829
1.02
0.10
3.1
3.1
ug/l
0.9
0.7
2.29
293
2619
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
56
1.07
0.08
1.3
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
85
824
1.03
0.08
1.2
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(4211845)
5
62
0.81
0.08
3.2
3.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
5
64
0.78
0.08
2.0
2.3
e6/l
568.2
836.1
—
5
54
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
65
0.77
0.08
2.4
1.5
ug/l
13.3
10.1
—
5
57
(3000475) Leukocytes [#/volume] in Synovial fluid
37
389
0.95
0.08
1.9
1.7
e6/l
13483.1
16648.8
0.26
26
279
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
74
0.81
0.07
3.0
3.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
83
0.84
0.07
1.0
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
9
84
1.07
0.07
1.6
1.4
—
64.5
—
0
11
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
122
0.90
0.07
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
40
415
0.96
0.05
1.7
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
40
414
0.97
0.05
1.5
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
140
1.07
0.04
1.3
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
47
482
0.97
0.03
1.0
1.1
—
156.9
—
0
14
(3002523) Influenza virus A Ag [Presence] in Specimen
15
141
1.06
0.03
1.3
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
17
179
0.95
0.03
1.1
1.0
—
—
—
0
0
(4268621)
13
122
1.07
0.02
2.2
2.3
—
—
—
0
0
(4281824)
12
128
0.94
0.02
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
50
510
0.98
0.02
1.3
1.6
—
—
—
0
0
(4306422)
17
162
1.05
0.02
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
48
489
0.98
0.02
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
34
347
0.98
0.01
2.7
3.2
nmol/l
0.8
0.8
0.14
28
269
(40768793) Breast Pathology biopsy report
23
236
0.97
0.00
1.4
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
18
178
1.01
0.00
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
131
1311
1.00
0.00
1.5
1.5
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
36.6
—
0
5
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
56
0.89
0.00
1.0
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
59
0.85
0.00
2.2
1.8
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
53
0.94
0.00
1.2
1.2
iu/ml
368.2
224.1
—
5
53
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.1
—
0
7
(3006462) Nitrate [Presence] in Urine
5
58
0.86
0.00
3.4
3.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
7
0.00
0.00
0.0
9.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_KIDNEY_CLEAR_CELL_CARCINOMA – Clear cell adenocarcinoma of kidney
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).